
Soleno Therapeutics SLNO
$ 40.55
-2.52%
Quarterly report 2025-Q3
added 11-04-2025
Soleno Therapeutics EV - Enterprise Value 2011-2026 | SLNO
Annual EV - Enterprise Value Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.95 B | 657 M | 18.9 M | -1.66 M | 126 M | 112 M | 25.7 M | 11 M | 12.5 M | 12.1 M | 12.5 M | 38.2 M | 36.7 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.95 B | -1.66 M | 232 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
990 K | $ 3.1 | 2.31 % | $ 101 K | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 24.05 | -2.67 % | $ 99.4 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 39.16 | -0.89 % | $ 1.09 B | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 33.54 | -5.15 % | $ 361 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 219.62 | -2.19 % | $ 161 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 102.3 | 0.05 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 26.24 | -0.61 % | $ 793 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.47 | -2.65 % | $ 1.87 M | ||
|
Guardant Health
GH
|
6.94 B | $ 110.48 | 0.68 % | $ 13.6 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | - | - | $ 79.8 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.68 | 0.56 % | $ 4.61 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
52.4 B | $ 74.0 | 0.87 % | $ 28.6 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 20.8 | 1.66 % | $ 1.12 B | ||
|
NeoGenomics
NEO
|
1.9 B | $ 12.4 | 0.16 % | $ 1.57 B | ||
|
Celcuity
CELC
|
506 M | $ 112.12 | -2.1 % | $ 4.42 B | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 10.3 | -6.02 % | $ 292 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Precipio
PRPO
|
10.9 M | $ 24.26 | -1.98 % | $ 31.5 M | ||
|
Personalis
PSNL
|
229 M | $ 9.97 | -0.2 % | $ 591 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 149.69 | -0.11 % | $ 23.8 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 235.62 | -1.73 % | $ 42.7 B | ||
|
Thermo Fisher Scientific
TMO
|
202 B | $ 592.16 | -2.61 % | $ 226 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.87 | -4.13 % | $ 61.9 M | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 211.68 | -2.4 % | $ 10.9 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 41.58 | -1.02 % | $ 2.49 B | ||
|
Medpace Holdings
MEDP
|
10.8 B | $ 593.07 | -0.81 % | $ 18.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 182.35 | -0.21 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
142 M | $ 9.66 | -6.49 % | $ 1.25 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 269.81 | 0.66 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 392.8 | -0.63 % | $ 29.6 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 185.89 | -0.23 % | $ 15.3 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 676.71 | -1.6 % | $ 55.8 B |